QA: Lumos Pharma INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001126234_2024_Lumos_Pharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001126234, Lumos Pharma INC

  xvar xval
0 AssetsCurrent 40,035,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 603,000
4 LiabilitiesCurrent 7,030,000
5 LiabilitiesNoncurrent 303,000
6 remainder_Liabilities 6,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,589,054
9 ResearchAndDevelopmentExpense 21,823,268
10 remainder_Expenses -25,216
11 remainder_Revenues 2,050,999
12 remainder_NetIncome 2,005,537
13 remainder_ComprehensiveNetIncome -8,999
  yvar yval
0 Assets 40,638,000
1 Liabilities 13,333,000
2 Expenses 38,387,106
3 Revenues 2,050,999
4 StockholdersEquity 27,305,000
5 NetIncome -34,330,570
6 ComprehensiveNetIncome -34,335,070
7 BaseVar 48,211,820
8 EconomicCapitalRatiobeforeLimitedLiability 0.933
9 EconomicCapitalRatio 2.25

Edgar->Model Mapping

Feature Distribution

Change over Time